New CEOs at Ergéa

Pan-European diagnostic specialist Ergéa has appointed David Rolfe as Group CEO and Mark Graves as CEO of Ergéa UK.

Rolfe (pictured), who was previously UK CEO, has more than 20 years of healthcare leadership experience and is a co-founder of two businesses that later merged with others to form the foundation of Ergéa UK.

During his tenure as UK CEO from 2017 to 2025, he led the organisation through a period of strong growth and cultural integration.

In his new role, he will strengthen alignment and collaboration between group and regional operations, accelerate its expansion into new markets, and continue to invest in medical technologies that enhance patient care.

Local CEOs and founding doctors will remain closely involved in shaping the group’s strategy and operations.

‘David is an experienced and respected leader with a strong track record in transformational leadership and deep experience in healthcare. His thorough understanding of our group will enable him to lead with insight from day one, ensuring our growth plans move forward with clarity and focus,’ said Dr Guglielmo Brayda di Soleto, co-chairman of Ergéa.

Graves was previously director of operations at Ergéa UK. Prior to joining the business in 2022, he held senior roles at Getinge, Johnson & Johnson, Olympus and GE Healthcare.